| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.03B | +4.0% |
| Gross Profit | $2.39B | +2.8% |
| R&D Expense | $199.4M | +5.3% |
| SG&A Expense | $998.3M | +6.6% |
| Interest Expense | $68.5M | -8.2% |
| Pre-tax Income | $1.05B | +1.1% |
| Income Tax | $179.7M | +3.2% |
| Net Income | $869.2M | +0.7% |
| EPS (Basic) | $42.17 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $778.2M | +13.3% |
| Inventory | $387.2M | +13.1% |
| Current Assets | $1.36B | +14.1% |
| Total Assets | $3.71B | +14.6% |
| Current Liabilities | $1.20B | +2.6% |
| Long-term Debt | $2.09B | +14.0% |
| Total Liabilities | $3.74B | +11.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $955.8M | -1.3% |
| Capital Expenditures | $107.1M | +3.1% |
| Investing Cash Flow | -$193.9M | -62.3% |
| Financing Cash Flow | -$755.2M | +11.8% |
| Free Cash Flow | $848.6M | -1.8% |
| +3.7% |
| EPS (Diluted) | $42.05 | +3.9% |
| Stockholders' Equity |
| -$23.6M |
| +81.4% |